North African and Southeast Asian nasopharyngeal carcinomas: Between the resemblance and the dissemblance;Le carcinome nasopharyngé en Afrique du Nord et dans le Sud-Est asiatique: Entre similitude et différence

Bulletin du Cancer

Volumn 97, Issue 4, 2010, Pages 475-482

  Ayadi, W ^a,b   Khabir, A ^a   Hadhri Guiga, B ^b   Fki, L ^a   Toumi, N ^a   Siala, W ^a   Charfi, S ^a   Fendri, A ^b   Makni, H ^c   Boudawara, T ^a   Ghorbel, A ^a   Gargouri, A ^b   Jlidi, R ^d   Gargouri, R ^b   Busson, P ^e   Drira, M ^c   Daoud, J ^a,f   Frikha, M ^a,f   Hammami, A ^a   Karray Hakim, H ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

^b CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

^c HEDI CHAKER HOSPITAL   (Tunisia)

^d UNIVERSITY OF SFAX   (Tunisia)

^e UMR 8126   (France)

^f Arome Association de Radiotherapie et d'Oncologie de la Mediterranee   (Tunisia)

Author keywords

Etiological pathogeny; North Africa; NPC; Southeast of asia

Indexed keywords

ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P53; STEM CELL FACTOR RECEPTOR; APOPTOSIS REGULATORY PROTEIN; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; MATRIX PROTEIN; TUMOR PROTEIN;

CANCER INCIDENCE; CANCER SURVIVAL; CHROMOSOME ABERRATION; EPSTEIN BARR VIRUS; GENETIC POLYMORPHISM; GEOGRAPHIC DISTRIBUTION; HUMAN; NASOPHARYNX CARCINOMA; NORTH AFRICA; PROMOTER REGION; REVIEW; SOUTHEAST ASIA; VIRUS CARCINOGENESIS; ADOLESCENT; ADULT; AFRICA; AGE DISTRIBUTION; ARTICLE; ETHNOLOGY; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGY; INCIDENCE; METABOLISM; NASOPHARYNX TUMOR;

ADOLESCENT; ADULT; AFRICA, NORTHERN; AGE DISTRIBUTION; APOPTOSIS REGULATORY PROTEINS; ASIA, SOUTHEASTERN; CHROMOSOME ABERRATIONS; EPIGENESIS, GENETIC; HERPESVIRUS 4, HUMAN; HUMANS; INCIDENCE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-KIT; TUMOR SUPPRESSOR PROTEIN P53; VIRAL MATRIX PROTEINS; YOUNG ADULT;

EID: 77952178819     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2010.1090     Document Type: Article

References (59)

1. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 2002; 12: 421-429
2. Bouaouina N, Kabbaj O, Bouzouita K, Boussen H, Ghannem H, Harrabi I, et al. Le cancer du cavum de l'enfant. Cancer Radiother 2000; S4: S162-1S3.
3. Khabir A, Sellami A, Sakka M, Ghorbel AM, Daoud J, Frikha M, et al. Contrasted frequencies of p53 accumulation in the two age groups of North African nasopharyngeal carcinomas. Clin Cancer Res 2000; 6: 3932-3936
4. Lo KW, Teo PM, Hui AB, To KF, Tsang YS, Chan SY, et al. High-resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 2000; 60: 3348-3353 (Pubitemid 30482144)
5. Lo KW, Huang DP. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 2002; 12: 451-462
6. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nature Rev 2004; 4: 757-768
7. Chua DT, Nicholls JM, Sam JS, Au GK. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2004; 59: 11-20.
8. Sheu LF, Chen A, Meng CL, Ho KC, Lin FG, Lee WH. Analysis of Bcl-2 expression in normal, inflamed, dysplastic nasopharyngeal epithelia and nasopharyngeal carcinoma: association with p53 expression. Hum Pathol 1997; 28: 556-562 (Pubitemid 27213052)
9. Khabir A, Ghorbel A, Daoud J, Frikha M, Drira MM, Laplanche A, et al. Similar Bcl-X but different Bcl-2 levels in the two age groups of North African nasopharyngeal carcinomas. Cancer Detect Prev 2003; 27: 250-255 (Pubitemid 36990242)
10. Sheu LF, Chen A, Tseng HH, Leu FJ, Lin JK, Ho KC, et al. Assessment of p53 expression in nasopharyngeal carcinoma. Hum Pathol 1995; 26: 380-386
11. Lung ML, Hu Y, Cheng Y, Li MF, Tang CM, Sai-Ki O, et al. p53 inactivating mutations in Chinese nasopharyngeal carcinomas. Cancer Lett 1998; 133: 89-94. (Pubitemid 29070481)
12. Cheng Q, Liu G, Wu Z, Wu Y, Xiao B. Bcl-2, p53 expression and Epstein-Barr virus infection in primary nasopharyngeal carcinoma. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2001; 15: 455-457
13. Niemhom S, Kitazawa S, Murao S, Kunachak S, Maeda S. Coexpression of p53 and Bcl-2 may correlate to the presence of Epstein-Barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma. Cancer Lett 2000; 160: 199-208.
14. Petitjean A, Achatz MIW, Borresen-Dale AL, Hainaut P, Olivier M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 2007; 26: 2157-2165 (Pubitemid 46536647)
15. Sheu LF, Chen A, Lee HS, Hsu HY, Yu DS. Cooperative interactions among p53, Bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells. Pathol Int 2004; 54: 475-485
16. Khabir A, Karray H, Rodriguez S, Rosé M, Daoud J, Frikha M, et al. EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in North African nasopharyngeal carcinomas. Virol J 2005; 2: 39. (Pubitemid 40973386)
17. Fendri A, Khabir A, Hadri-Guiga B, Sellami-Boudaouara T, Ghorbel A, Drira M, et al. Overexpression of COX-2 and LMP1 are correlated with lymph node in Tunisian NPC patients. Oral Oncol 2008; 44: 710-715 (Pubitemid 351842824)
18. Ashman LK. The biology of stem cell factor and its receptor c-kit. Int J Biochem Cell Biol 1999; 31: 1037-1051
19. Coindre JM, Emile JF, Monges G, Ranchere-Vince D, Scoazec JY. Gastrointestinal stromal tumors: definition, histological, immunohistochemical and molecular features, and diagnostic strategy. Ann Pathol 2005; 25: 358-385
20. Gibson PC, Cooper K. CD117 (KIT): a diverse protein with selective applications in surgical pathology. Adv Anat Pathol 2002; 9: 65-69
21. Shuangshoti S, Pintong J, Keelawat S, Shuangshoti S. Expression of EGFR (epidermal growth factor receptor) and c-kit in nasopharyngeal carcinoma. J Health Sci 2006; 15: 75-79
22. Charfi S, Khabir A, Ayadi L, Mseddi M, Makni H, Ghorbel A, et al. Expression de c-kit dans les carcinomes nasopharyngés nord africains, corrélation avec l'âge et LMP1. Cancer Radiother 2007; 11: 247-251
23. Ho HC, Ng MH, Kwan HC, Chau JC. Epstein-Barr virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma. Br J Cancer 1976; 34: 655-660
24. Sam CK, Prasad U, Pathmanathan R. Serological markers in the diagnosis of histopathological types of nasopharyngeal carcinoma. Eur J Surg Oncol 1989; 15: 357-360 (Pubitemid 19212519)
25. Boualga K, Ghouadni R. Carcinoma of the nasopharynx in Algeria. A propos of a series of 213 cases. Ann Radiol 1984; 27: 621-628
26. Dardari R, Khyatti M, Benider A, Jouhadi H, Kahlain A, Cochet C, et al. Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma. Int J Cancer 2000; 86: 71-75 (Pubitemid 30133989)
27. Karray H, Ayadi W, Fki L, Hammami A, Daoud J, Drira MM, et al. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia. J Med Virol 2005; 75: 593-602. (Pubitemid 40293528)
28. Prince S, Keating S, Fielding C, Brennan P, Floettmann E, Rowe M. Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms. J Virol 2003; 77: 5000-5007 (Pubitemid 36402850)
29. Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, et al. Single-assay combination of Epstein-Barr virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening. J Clin Microbiol 2006; 44: 1459-1467
30. Dardari R, Hinderer W, Lang D, Benider A, El Gueddari B, Joab I, et al. Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: complementary test of ZEBRA protein and early antigens p54 and p138. J Clin Microbiol 2001; 39: 3164-3170 (Pubitemid 32830309)
31. Abdel-Hamid M, Chen JJ, Constantine N, Massoud M, Raab-Traub N. EBV strain variation: geographical distribution and relation to disease state. Virology 1992; 190: 168-175
32. Lung ML, Lam WP, Sham J, Yong-Sheng Z, Guo HY, Ng MH. Detection and prevalence of the f variant of Epstein-Barr virus in Southern China. Virology 1991; 185: 67-71.
33. See HS, Yap YY, Yip WK, Seow HF. Epstein-Barr virus latent membrane protein 1 (LMP1) 30 bp deletion and XhoI- loss is associated with type III nasopharyngeal carcinoma in Malaysia. World J Surg Oncol 2008; 6: 18-27.
34. Bouzid M, Sheng W, Buisson M, Bouguermouh A, Morand P, Seigneurin JM, et al. Different distribution of H1-H2 Epstein-Barr virus variant in oropharyngeal virus and in biopsies of Hodgkin's disease and in nasopharyngeal carcinoma from Algeria. Int J Cancer 1998; 77: 205-210 (Pubitemid 28287970)
35. Hadhri-Guiga B, Khabir AM, Mokdad-Gargouri R, Ghorbel AM, Drira M, Daoud J, et al. Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients. Virus Res 2006; 115: 24-30. (Pubitemid 41772478)
36. Ayadi W, Feki L, Khabir A, Boudawara T, Ghorbel A, Charfeddine I, et al. Polymorphism analysis of Epstein-Barr virus isolates of nasopharyngeal carcinoma biopsies from Tunisian patients. Virus Genes 2007; 34: 137-145 (Pubitemid 46411980)
37. Seigneurin JM. Epstein-Barr virus (EBV). Rev Prat 1999; 49: 2217-2221
38. Zhou XG, Sandvej K, Li PJ, Ji XL, Yan QH, Zhang XP, et al. Epstein-Barr virus gene polymorphisms in Chinese Hodgkin's disease cases and healthy donors: identification of three distinct virus variants. J Gen Virol 2001; 82: 1157-1167 (Pubitemid 32454615)
39. Chen ML, Tsai CN, Liang CL. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992; 7: 2131-2140
40. Li SN, Chang YS, Liu ST. Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 1996; 12: 2129-2135 (Pubitemid 26168422)
41. Goldsmith DB, West TM, Morton R. HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis. Clin Otolaryngol Allied Sci 2002; 27: 61-67 (Pubitemid 34264435)
42. Edwards RH, Sitki-Green D, Moore DT, Raab-Traub N. Potential selection of LMP1 variants in nasopharyngeal carcinoma. J Virol 2004; 78: 868-881 (Pubitemid 38067608)
43. Mokni-Baizig N, Ayed K, Ayed FB, Ayed S, Sassi F, Ladgham A. Association between HLA-A/-B antigens and -DRB1 alleles and nasopharyngeal carcinoma in Tunisia. Oncology 2001; 61: 55-58 (Pubitemid 32727588)
44. Dardari R, Khyatti M, Jouhadi H, Benider A, Ettayebi H, Kahlain A, et al. Study of human leukocyte antigen class I phenotypes in Moroccan patients with nasopharyngeal carcinoma. Int J Cancer 2001; 92: 294-297 (Pubitemid 32225383)
45. Hadhri-Guiga B, Toumi N, Khabir A, Sellami-Boudawara T, Ghorbel A, Daoud J, et al. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia. Cancer Genet Cytogenet 2007; 178: 89-93. (Pubitemid 47595352)
46. Tsai MH, Lin CD, Hsieh YY, Chang FC, Tsai FJ, Chen WC, et al. Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma. Laryngoscope 2002; 112: 116-119 (Pubitemid 34037747)
47. Tiwawech D, Srivatanakul P, Karaluk A, Ishida T. The p53 codon 72 polymorphism in Thai nasopharyngeal carcinoma. Cancer Lett 2003; 198: 69-75. (Pubitemid 37289105)
48. Hui AB, Lo KW, Leung SF, Teo P, Fung MKF, To KF, et al. Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridization. Int J Cancer 1999; 82: 498-503. (Pubitemid 29343447)
49. Fang Y, Guan XY, Guo Y, Sham JST, Deng M, Liang Q, et al. Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization. Gene Chromosomes Cancer 2001; 30: 254-260 (Pubitemid 32126201)
50. Rodriguez S, Khabir A, Keryer C, Perrot C, Drira M, Ghorbel A, et al. Conventional and array-based comparative genomic hybridization analysis of nasopharyngeal carcinomas from Mediterranean area. Cancer Genet Cytogenet 2005; 157: 140-147 (Pubitemid 40255193)
51. Kwong KW, Lo KF, To PML, Teo PJ, Johnson PJ, Huang DP. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 2002; 8: 131-137 (Pubitemid 34101468)
52. Kwong J, Chow LS, Wong AY, Hung WK, Chung GT, To KF, et al. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma. Genes Chromosomes Cancer 2007; 46: 171-180 (Pubitemid 44913382)
53. Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, Tsai ST, et al. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stressresponsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene 2004; 23: 4793-4806 (Pubitemid 38859468)
54. Fendri A, Masmoudi A, Khabir A, Sellami-Boudawara T, Ghorbel A, Drira M, et al. Inactivation of RASSF1A, RARb2 and DAP-Kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma (accepté dans Cancer biology & biotherapy).
55. Ayadi W, Karray-Hakim H, Khabir A, Feki L, Charfi S, Boudawara T, et al. Aberrant methylation of p16, DLEC1, BLU and Ecadherin gene promoters in nasopharyngeal carcinoma biopsies from Tunisian patients. Anticancer Res 2008; 28: 2161-2168
56. Tsao SW, Liu Y, Wang X, Yuen PW, Leung SY, Yuen ST, et al. The association of E-cadherin expression and the methylation status of the E-cadherin gene in nasopharyngeal carcinoma cells. Eur J Cancer 2003; 39: 524-531 (Pubitemid 36173698)
57. Wong TS, Tang KC, Kwong DL, Sham JS, Wei WI, Kwong YL, et al. Differential gene methylation in undifferentiated nasopharyngeal carcinoma. Int J Oncol 2003; 22: 869-874
58. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumor-suppressor gene. Trends Biochem Sci 1999; 24: 73-76 (Pubitemid 29346577)
59. Jmal A, Boussen H, Ghanem A, Abaza H, Gara S, Douik H, et al. Nasopharyngeal carcinoma in Tunisian children: retrospective epidemiological, clinical and biological study about 48 cases. Bull Cancer 2005; 92: 977-981 (Pubitemid 43001116)